62-year-old male with intermediate risk prostate cancer. Evaluate prostate and assess for high risk features.Per pathology report:Prostate, left base lateral; needle biopsy: Prostatic adenocarcinoma, Gleason grade 3+4=7.Prostate, left mid medial; needle biopsy: Prostatic adenocarcinoma, Gleason grade 4+3=7.Prostate, left mid lateral; needle biopsy: Prostatic adenocarcinoma, Gleason grade 4+3=7.Prostate, left apex medial; needle biopsy: Prostatic adenocarcinoma, Gleason grade 3+4=7.Prostate, left apex lateral; needle biopsy: Prostatic adenocarcinoma, Gleason grade 4+3=7. PELVIS:PROSTATE:Prostate Size: 4.7 x 3.0 cmPeripheral Zone: There are multiple lesions demonstrating T2 hypointensity with corresponding ADC hypointensity and enhancement as follows:The largest lesion is left mid gland to apex, extending anteriorly and measuring 1.3 x 0.7 cm; the capsule is indistinct in this area and focal extracapsular extension cannot be excluded.Left lateral base lesion measures 1.0 x 0.6 cm.Central Gland: Heterogeneous signal corresponding to benign prostatic hypertrophy. Seminal Vesicles: No evidence of extension into the seminal vesicles.Extracapsular Extension: The capsule is indistinct in the left mid gland to apex at the anterior aspect and extracapsular extension cannot be excluded in this area.BLADDER: No significant abnormality noted.LYMPH NODES: Left external iliac chain lymph node measures 1.1 x 1.1 cm (series 2301, image 84). Left pelvic sidewall lymph node measures 0.8 x 0.4 cm (series 82301, image 113). BONES, SOFT TISSUES: Changes at L5/S1 are better evaluated on the recent lumbar spine MRI 10/9/2015OTHER: No significant abnormality noted.
1.Multiple prostatic lesions consistent with known adenocarcinoma. 2.Pelvic lymphadenopathy and findings suspicious for extracapsular extension as above.3.Changes at L5/S1 are better evaluated on the recent lumbar spine MRI 10/9/2015